Tenofovir disoproxil fumarate and Rash for Men aged 30-39 (a phase IV clinical study of FDA data)

Summary:

Rash is found for men aged 30-39 who take Tenofovir disoproxil fumarate (tenofovir disoproxil fumarate). This study is created by eHealthMe based on reports of 485 men aged 30-39 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Tenofovir disoproxil fumarate when people have Rash
Top conditions
Top co-used drugs
Top other side effects

On Dec, 07, 2025

485 men aged 30-39 reported to have side effects when taking Tenofovir disoproxil fumarate.
Among them, 16 people (3.3%) have Rash

What is Tenofovir disoproxil fumarate?

Tenofovir disoproxil fumarate has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 9,957 Tenofovir disoproxil fumarate users. Check the latest studies of Tenofovir disoproxil fumarate.

What is Rash?

Rash is found to be associated with 4,020 drugs and 6,191 conditions by eHealthMe. Check the latest studies of Rash.

Number of reports submitted per year:

Could Tenofovir disoproxil fumarate cause Rash in men aged 30-39?

Time on Tenofovir disoproxil fumarate when people have Rash *

Severity of Rash

n/a

How people recovered from Rash

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 6.25%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Fever: 4 people, 25.00%
Itching: 4 people, 25.00%
Laryngeal Oedema (swelling of larynx): 4 people, 25.00%
Oedema (fluid collection in tissue): 4 people, 25.00%
Diarrhea: 3 people, 18.75%
Muscle Aches (muscle pain): 3 people, 18.75%
Mycobacterium Avium Complex Infection: 3 people, 18.75%
Immune Reconstitution Syndrome (immune recovery syndrome): 2 people, 12.50%
Nausea And Vomiting: 2 people, 12.50%
Colorectal Cancer Stage Iv (cancer of colon and rectal spreads to liver or lung): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Tenofovir disoproxil fumarate and have Rash?

- Check whether Rash is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related publications that referenced our studies:

Mohammad MM, Syrigos KN, Saif MW, "Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma", Case reports in dermatological medicine, 2013 Sep .
Mohammad MM, Syrigos KN, Saif MW, "Association between Rash and a Positive Drug Response Associated with Vinorelbine in a Patient with Primary Peritoneal Carcinoma", Case reports in dermatological medicine, 2013 Sep .

Related studies:

Tenofovir disoproxil fumarate and Rash

How the study uses the data?

The study is based on (applicable) gender, age, tenofovir disoproxil fumarate (the active ingredients of Tenofovir disoproxil fumarate) and Tenofovir disoproxil fumarate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.